SE8701905D0 - A method and a kit for the diagnosis of iga nephropathy - Google Patents

A method and a kit for the diagnosis of iga nephropathy

Info

Publication number
SE8701905D0
SE8701905D0 SE8701905A SE8701905A SE8701905D0 SE 8701905 D0 SE8701905 D0 SE 8701905D0 SE 8701905 A SE8701905 A SE 8701905A SE 8701905 A SE8701905 A SE 8701905A SE 8701905 D0 SE8701905 D0 SE 8701905D0
Authority
SE
Sweden
Prior art keywords
diagnosis
pct
substrate
iga
complex
Prior art date
Application number
SE8701905A
Other languages
English (en)
Other versions
SE8701905L (sv
SE461616B (sv
Inventor
B Cederholm
J Wieslander
P Bygren
D Heinegard
Original Assignee
Biocarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocarb Ab filed Critical Biocarb Ab
Priority to SE8701905A priority Critical patent/SE461616B/sv
Publication of SE8701905D0 publication Critical patent/SE8701905D0/sv
Priority to DE8888904694T priority patent/DE3865678D1/de
Priority to US07/431,546 priority patent/US5139932A/en
Priority to PCT/SE1988/000240 priority patent/WO1988008983A1/en
Priority to EP88904694A priority patent/EP0363397B1/en
Priority to AT88904694T priority patent/ATE68600T1/de
Priority to JP63504340A priority patent/JP2592121B2/ja
Publication of SE8701905L publication Critical patent/SE8701905L/sv
Publication of SE461616B publication Critical patent/SE461616B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8701905A 1987-05-08 1987-05-08 Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex SE461616B (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE8701905A SE461616B (sv) 1987-05-08 1987-05-08 Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex
DE8888904694T DE3865678D1 (de) 1987-05-08 1988-05-09 Satz und verfahren zur diagnose der iga-nephropathie.
US07/431,546 US5139932A (en) 1987-05-08 1988-05-09 Method and a kit for the diagnosis of iga nephropathy
PCT/SE1988/000240 WO1988008983A1 (en) 1987-05-08 1988-05-09 A METHOD AND A KIT FOR THE DIAGNOSIS OF IgA NEPHROPATHY
EP88904694A EP0363397B1 (en) 1987-05-08 1988-05-09 A method and a kit for the diagnosis of iga nephropathy
AT88904694T ATE68600T1 (de) 1987-05-08 1988-05-09 Satz und verfahren zur diagnose der iganephropathie.
JP63504340A JP2592121B2 (ja) 1987-05-08 1988-05-09 ＩｇＡ腎臓病の診断のための方法及びキツト

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701905A SE461616B (sv) 1987-05-08 1987-05-08 Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex

Publications (3)

Publication Number Publication Date
SE8701905D0 true SE8701905D0 (sv) 1987-05-08
SE8701905L SE8701905L (sv) 1988-11-09
SE461616B SE461616B (sv) 1990-03-05

Family

ID=20368457

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701905A SE461616B (sv) 1987-05-08 1987-05-08 Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex

Country Status (7)

Country Link
US (1) US5139932A (sv)
EP (1) EP0363397B1 (sv)
JP (1) JP2592121B2 (sv)
AT (1) ATE68600T1 (sv)
DE (1) DE3865678D1 (sv)
SE (1) SE461616B (sv)
WO (1) WO1988008983A1 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005190A1 (en) * 1988-12-12 1990-06-12 Morgan Van Aken Detection of basement membrane components as diagnostic of cancer and other diseases
EP0514928B1 (en) * 1991-05-24 1997-08-20 Wakamoto Pharmaceutical Co., Ltd. Method of diagnosing renal diseases by detecting albumin fragments
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US6255281B1 (en) * 1997-05-28 2001-07-03 Claragen, Inc. And U.S. Government Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
JP4197393B2 (ja) 1998-03-31 2008-12-17 旭化成ファーマ株式会社 ＩｇＡ腎症の検査法
AU2001280651A1 (en) * 2000-07-19 2002-01-30 Battelle Memorial Institute Assay for identifying theta2u-globulin-mediated nephropathy
FI20010868A0 (sv) * 2001-04-25 2001-04-25 Markku Maeki Förfarande och medel för att detektera gluteninducerade sjukdomar
WO2007019376A2 (en) 2005-08-03 2007-02-15 Rq Bioscience, Inc. Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
KR101644120B1 (ko) * 2008-06-02 2016-07-29 에디아 가부시키가이샤 ＩｇＡ 신증의 검사 방법 및 검사 키트
WO2009147999A1 (ja) * 2008-06-02 2009-12-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 ＩｇＡ腎症の検査方法及び検査キット
EP2442105B1 (en) 2009-06-10 2015-01-07 Niigata University Test method on renal diseases
US9339526B2 (en) 2011-01-17 2016-05-17 University Of Manitoba Methods for treating disorders that involve immunoglobulin A
US9598733B2 (en) 2011-02-17 2017-03-21 The Trustees Of Columbia University In The City Of New York Methods for identifying subjects with a genetic risk for developing IgA nephropathy
WO2014169294A1 (en) 2013-04-12 2014-10-16 The Trustees Of Columbia University In The City Of New York Mutations in dstyk cause dominant urinary tract malformations
JP7473398B2 (ja) 2020-05-28 2024-04-23 シスメックス株式会社 キャリブレータ、複合体、及びＩｇＡ凝集体を測定する方法

Also Published As

Publication number Publication date
EP0363397B1 (en) 1991-10-16
ATE68600T1 (de) 1991-11-15
JP2592121B2 (ja) 1997-03-19
SE8701905L (sv) 1988-11-09
US5139932A (en) 1992-08-18
SE461616B (sv) 1990-03-05
WO1988008983A1 (en) 1988-11-17
EP0363397A1 (en) 1990-04-18
JPH02503714A (ja) 1990-11-01
DE3865678D1 (de) 1991-11-21

Similar Documents

Publication Publication Date Title
SE8701905D0 (sv) A method and a kit for the diagnosis of iga nephropathy
DE69412137D1 (de) Sensoreinrichtung zum sandwichtest
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
DE3587687D1 (de) Monoklonale Antikörper für HbA1c.
DE69033796D1 (de) Verfahren und gerät zum nachweis und zur quantifizierung von glukose in körperflüssigkeiten
ATE123653T1 (de) Vernetzte antikörper und verfahren zu ihrer herstellung.
NO991693L (no) Forbindelser og metoder for diagnose av tuberkulose
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
ATE115729T1 (de) Testverfahren und reagenziensatz dafür.
CA2005300A1 (en) Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
ES2131690T3 (es) Dispositivo para la dosificacion de haptenos y su utilizacion.
ATE123952T1 (de) Vernetzte antikörper und verfahren zu ihrer herstellung.
GR3022078T3 (en) Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
ATE24241T1 (de) Verfahren zur feststellung und bestimmung eines biologischen stoffes durch erythroadsorption.
DE69524107D1 (de) Bestimmung von freiem und komplexiertem trypsinogen-2
DE3863270D1 (de) Immuntest.
DK479687A (da) Antistoffer mod modificeret beta2-mikroglobulin samt diagnostika og praeparater indeholdende disse
UA51131A (uk) Спосіб діагностики аутоімунних захворювань печінки

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8701905-5

Effective date: 19921204

Format of ref document f/p: F